Blood Res.  2016 Dec;51(4):215-216. 10.5045/br.2016.51.4.215.

Mixed-phenotype acute leukemia (MPAL) and beyond

• Kim HJ

• KMID: 2364307
• DOI: http://doi.org/10.5045/br.2016.51.4.215

Abstract

No abstract available.

MeSH Terms

Leukemia*

Reference

1. Matutes E, Pickl WF, Van't Veer M, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011; 117:3163–3171. PMID: 21228332.

2. Nishiuchi T, Ohnishi H, Kamada R, et al. Acute leukemia of ambiguous lineage, biphenotype, without CD34, TdT or TCR-rearrangement. Intern Med. 2009; 48:1437–1441. PMID: 19687594.

3. Deshpande AJ, Buske C. Lymphoid progenitors as candidate cancer stem cells in AML: new perspectives. Cell Cycle. 2007; 6:543–545. PMID: 17329976.

4. Yan M, Kanbe E, Peterson LF, et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med. 2006; 12:945–949. PMID: 16892037.

5. Wolach O, Stone RM. How I treat mixed-phenotype acute leukemia. Blood. 2015; 125:2477–2485. PMID: 25605373.

6. Weinberg OK, Seetharam M, Ren L, Alizadeh A, Arber DA. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria. Am J Clin Pathol. 2014; 142:803–808. PMID: 25389334.

7. van den Ancker W, Terwijn M, Westers TM, et al. Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification. Leukemia. 2010; 24:1392–1396. PMID: 20485373.

8. Munker R, Brazauskas R, Wang HL, et al. Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia. Biol Blood Marrow Transplant. 2016; 22:1024–1029. PMID: 26903380.

9. Pomerantz A, Rodriguez-Rodriguez S, Demichelis-Gomez R, et al. Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used. Blood Research. 2016; 51:233–241.

10. Eckstein OS, Wang L, Punia JN, et al. Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. Exp Hematol. 2016; 44:740–744. PMID: 27208809.